nach oben

Documenta Ophthalmologica

Erschienen in:

01.06.2013 | Original Research Article

Functional protective effects of long-term memantine treatment in the DBA/2J mouse

verfasst von: Jenny Atorf, Michael Scholz, Fabian Garreis, Julia Lehmann, Lars Bräuer, Jan Kremers

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyse the effects of long-term memantine treatment on the retinal physiology and morphology of DBA/2J mice.

Methods

DBA/2J (D2J) mice received i.p. injections of the NMDA receptor antagonist memantine, which protects neurons from abnormally elevated glutamate levels, twice a day over a period of 7 months. At the age of 2, 6 and 10 months, the intraocular pressure (IOP) and electroretinograms (ERGs) were measured in all treated D2J mice, in untreated D2J controls and in C57Bl/6 (B6) wild-type mice. After the last measurement at the age of 10 months, the mice were killed and the retinae and the optic nerves were analysed morphologically.

Results

The IOP increased with age in both D2J and B6 mice with a larger increase in the D2J strain. IOPs were not influenced by memantine treatment. The response amplitude of the scotopic flash ERG decreased with age in the D2J strain. This amplitude decrease, particularly that of the b-wave, was smaller in treated D2J mice. The retinae of treated D2J mice exhibited less peripheral degeneration of cone photoreceptors, and optic nerve neuropathy was less frequent.

Conlcusions

Application of the NMDA receptor antagonist memantine diminished retinal neurodegeneration in the D2J mice and had a protective effect on the b-wave amplitude of the scotopic flash ERG. This protection may occur secondarily as memantine primarily acts on retinal ganglion cells.

Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, Wiggs JL, John SWM (2002) Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 30(1):81–85PubMedCrossRef

John SWM, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull M, Roderick TH, Heckenlively JR (1998) Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39(6):951–962PubMed

Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O, Roderick TH, Heckenlively JR, Davisson MT, John SW (1999) Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 21(4):405–409. doi:10.1038/7741 PubMedCrossRef

Libby RT, Anderson MG, Pang IH, Robinson ZH, Savinova OV, Cosma IM, Snow A, Wilson LA, Smith RS, Clark AF, John SWM (2005) Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci 22(5):637–648PubMedCrossRef

Saleh M, Nagaraju M, Porciatti V (2007) Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 48(10):4564–4572PubMedCrossRef

Scholz M, Buder T, Seeber S, Adamek E, Becker CM, Lütjen-Drecoll E (2008) Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest Ophthalmol Vis Sci 49(2):613–621PubMedCrossRef

Moon JI, Kim IB, Gwon JS, Park MH, Kang TH, Lim EJ, Choi KR, Chun MH (2005) Changes in retinal populations in the DBA/2J mouse. Cell Tissue Res 320(1):51–59PubMedCrossRef

Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW (2006) Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7:66PubMedCrossRef

Porciatti V, Saleh M, Nagaraju M (2007) The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 48(2):745–751PubMedCrossRef

10.

Harazny J, Scholz M, Buder T, Lausen B, Kremers J (2009) Electrophysiological deficits in the retina of the DBA/2J mouse. Doc Ophthalmol 119(3):181–197PubMedCrossRef

11.

Barabas P, Huang W, Chen H, Koehler CL, Howell G, John SW, Tian N, Renteria RC, Krizaj D (2011) Missing optomotor head-turning reflex in the DBA/2J mouse. Invest Ophthalmol Vis Sci 52(9):6766–6773. doi:10.1167/iovs.10-7147 PubMedCrossRef

12.

Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1(8):623–634PubMedCrossRef

13.

Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11(9):379–387PubMedCrossRef

14.

Lipton SA, Rosenberg RA (1994) Mechanisms of disease: excitatory amino acids as a final common pathway in neurologic disorders. N Engl J Med 330(9):613–622PubMedCrossRef

15.

Lucas DR, Newhouse JP (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58(2):193–201PubMedCrossRef

16.

Olney JW (1969) Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 28(3):455–474PubMedCrossRef

17.

Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB (1996) Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 37(8):1618–1624PubMed

18.

Hare WA, Wheeler L (2009) Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine. Invest Ophthalmol Vis Sci 50(6):2940–2948PubMedCrossRef

19.

Clapham DE (1995) Calcium signaling. Cell 80(2):259–268PubMedCrossRef

20.

Schanne FA, Kane AB, Young EE, Farber JL (1979) Calcium dependence of toxic cell death: a final common pathway. Science 206(4419):700–702PubMedCrossRef

21.

Trump BF, Berezesky IK (1995) Calcium-mediated cell injury and cell death. FASEB J 9(2):219–228PubMed

22.

Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166(3):591–592PubMedCrossRef

23.

Kornhuber J, Bormann J, Retz W, Hubers M, Riederer P (1989) Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166(3):589–590PubMedCrossRef

24.

Seif el Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J (1990) Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 185(1):19–24PubMedCrossRef

25.

Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12(11):4427–4436PubMed

26.

Lipton SA (1993) Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 16(12):527–532PubMedCrossRef

27.

Schneider E, Fischer PA, Clemens R, Balzereit F, Fünfgeld EW, Haase HJ (1984) Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study. Dtsch Med Wochenschr 109(25):987–990. doi:10.1055/s-2008-1069311 PubMedCrossRef

28.

Greenamyre JT, O’Brien CF (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson’s disease. Arch Neurol 48(9):977–981PubMedCrossRef

29.

Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F (2002) Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 33(7):1834–1839PubMedCrossRef

30.

Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 348(14):1333–1341. doi:10.1056/NEJMoa013128 PubMedCrossRef

31.

Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 33(4):403–407. doi:10.1002/ana.410330414 PubMedCrossRef

32.

Lagreze WA, Knorle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39(6):1063–1066PubMed

33.

Schuettauf F, Quinto K, Naskar R, Zurakowski D (2002) Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res 42(20):2333–2337PubMedCrossRef

34.

Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 48(3):1212–1218. doi:10.1167/iovs.06-0757 PubMedCrossRef

35.

Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, Ellisman MH, Weinreb RN (2009) Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 50(2):707–716. doi:10.1167/iovs.08-2499 PubMedCrossRef

36.

Filippopoulos T, Matsubara A, Danias J, Huang W, Dobberfuhl A, Ren L, Mittag T, Miller JW, Grosskreutz CL (2006) Predictability and limitations of non-invasive murine tonometry: comparison of two devices. Exp Eye Res 83(1):194–201PubMedCrossRef

37.

Goldblum D, Kontiola AI, Mittag T, Chen B, Danias J (2002) Non-invasive determination of intraocular pressure in the rat eye. Comparison of an electronic tonometer (TonoPen), and a rebound (impact probe) tonometer. Graefes Arch Clin Exp Ophthalmol 240:942–946PubMedCrossRef

38.

Danias J, Kontiola AI, Filippopoulos T, Mittag T (2003) Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci 44(3):1138–1141PubMedCrossRef

39.

Zhang K, Yao G, Gao Y, Hofeldt KJ, Lei B (2007) Frequency spectrum and amplitude analysis of dark- and light-adapted oscillatory potentials in albino mouse, rat and rabbit. Doc Ophthalmol 115(2):85–93PubMedCrossRef

40.

Birke MT, Neumann C, Birke K, Kremers J, Scholz M (2010) Changes of osteopontin in the aqueous humor of the DBA/2J glaucoma model correlated with optic nerve and RGC degenerations. Invest Ophthalmol Vis Sci 51(11):5759–5767. doi:10.1167/iovs.10-5558 PubMedCrossRef

41.

Inman DM, Sappington RM, Horner PJ, Calkins DJ (2006) Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci 47(3):986–996PubMedCrossRef

42.

Howell GR, Libby RT, Marchant JK, Wilson LA, Cosma IM, Smith RS, Anderson MG, John SW (2007) Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet 8:45PubMedCrossRef

43.

Samuel MA, Zhang Y, Meister M, Sanes JR (2011) Age-related alterations in neurons of the mouse retina. J Neurosci 31(44):16033–16044. doi:10.1523/jneurosci.3580-11.2011 PubMedCrossRef

44.

Stockton RA, Slaughter MM (1989) B-wave of the electroretinogram: a reflection of ON bipolar activity. J Gen Physiol 93(1):101–122PubMedCrossRef

45.

Hare WA, WoldeMussie E, Lai RK, Ton H, Ruiz G, Chun T, Wheeler L (2004) Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey I: functional measures. Invest Ophthalmol Vis Sci 45(8):2625–2639PubMedCrossRef

46.

Porciatti V (2007) The mouse pattern electroretinogram. Doc Ophthalmol 115(3):145–153. doi:10.1007/s10633-007-9059-8 PubMedCrossRef

47.

Miura G, Wang MH, Ivers KM, Frishman LJ (2009) Retinal pathway origins of the pattern ERG of the mouse. Exp Eye Res 89(1):49–62. doi:10.1016/j.exer.2009.02.009 PubMedCrossRef

48.

Nagaraju M, Saleh M, Porciatti V (2007) IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci 48(10):4573–4579PubMedCrossRef

49.

Danias J, Lee KC, Zamora MF, Chen B, Shen F, Filippopoulos T, Su Y, Goldblum D, Podos SM, Mittag T (2003) Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57BL/6 mice. Invest Ophthalmol Vis Sci 44:5151–5162PubMedCrossRef

50.

Jakobs TC, Libby RT, Ben Y, John SWM, Masland RH (2005) Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171(2):313PubMedCrossRef

51.

Howell GR, Libby RT, Jakobs TC, Smith RS, Phalam FC, Barter JW, Barbay JM, Marchant JK, Nagaraju M, Porciatti V, Whitmore AV, Masland RH, John SWM (2007) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 179(7):1523–1537PubMedCrossRef

52.

Schuettauf F, Rejdak R, Walski M, Frontczak-Baniewicz M, Voelker M, Blatsios G, Shinoda K, Zagorski Z, Zrenner E, Grieb P (2004) Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol 107(4):352–358. doi:10.1007/s00401-003-0816-9 PubMedCrossRef

Titel: Functional protective effects of long-term memantine treatment in the DBA/2J mouse
verfasst von: Jenny Atorf
Michael Scholz
Fabian Garreis
Julia Lehmann
Lars Bräuer
Jan Kremers
Publikationsdatum: 01.06.2013
Verlag: Springer-Verlag
Erschienen in: Documenta Ophthalmologica / Ausgabe 3/2013
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI: https://doi.org/10.1007/s10633-013-9380-3

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Functional protective effects of long-term memantine treatment in the DBA/2J mouse

Abstract

Purpose

Methods

Results

Conlcusions

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

Bestmögliche Wundheilung der Kornea dank optimaler pharmakologischer Therapie

Update Augenheilkunde

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conlcusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Multifocal electroretinographic evaluation of macular function in acute posterior multifocal placoid pigment epitheliopathy

Erratum to: Can we do without mydriasis in multifocal ERG recordings?

Decreased retinal–choroidal blood flow in retinitis pigmentosa as measured by MRI

Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient

Spectral domain optical coherence tomography findings in bilateral peripheral cone dystrophy

Evaluation of structural and functional changes in non-pathologic myopic fundus using multifocal electroretinogram and optical coherence tomography

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

Bestmögliche Wundheilung der Kornea dank optimaler pharmakologischer Therapie

Update Augenheilkunde